Cytek Biosciences, Inc.
Health
Performance
7.7
Risk
Sell
Buy
Curious about the Scores? Learn more.

Cytek Biosciences, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

16.01.2026
Off life support. Still risky, but slightly less scary.
26.11.2025
Breaking down. The red game over screen is flashing.
20.08.2025
Pulse detected. Still fragile, but stabilizing.

Cytek Biosciences, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Cytek Biosciences, Inc. do? Business model and key facts

Get the full picture of Cytek Biosciences, Inc.: what it builds, where it operates, and how it makes money.

Cytek Biosciences, Inc. Profile

Sector: Healthcare

Industry: Medical - Devices

Employees (FY): 663

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, which are automated plate loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

shop
Company facts
Wenbin Jiang
CEO
663
Employees worldwide
shop
Performance
-1.06%
Last 12 months
-70.04%
Last 5 years
shop
Growth
$200,45M
Revenue year
$-6.020.000
Net income
shop
Valuation
$718,59M
Market Cap
-140.81
Price/Earnings Ratio

Stocks related to Cytek Biosciences, Inc.

Selected based on industry alignment and relative market positioning.

SIBN
SI-BONE, Inc.
17.09
-2.76%
6.8
Sell
Buy
SI-BONE, Inc.
INMD
InMode Ltd.
13.93
-0.89%
6.5
Sell
Buy
InMode Ltd.
IART
Integra LifeSciences Holdings Corporation
12.36
-2.33%
8.4
Sell
Buy
Integra LifeSciences Holdings Corporation
PACB
Pacific Biosciences of California, Inc.
2.27
-3.62%
9.2
Sell
Buy
Pacific Biosciences of California, Inc.
TCMD
Tactile Systems Technology, Inc.
30.35
-0.46%
5.7
Sell
Buy
Tactile Systems Technology, Inc.

Cytek Biosciences, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.